Header Logo

Connection

Alan Landay to Interleukin-2

Back to Details
This is a "connection" page, showing publications Alan Landay has written about Interleukin-2.
Alan Landay
Connection Strength
0.873
Interleukin-2
  1. A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment. J Interferon Cytokine Res. 2011 Jun; 31(6):481-3.
    View in: PubMed
    Score: 0.093
  2. Liver X receptor alpha (LXRalpha) as a therapeutic target in chronic lymphocytic leukemia (CLL). J Leukoc Biol. 2009 Nov; 86(5):1019-21.
    View in: PubMed
    Score: 0.086
  3. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS. 2009 Mar 13; 23(5):605-10.
    View in: PubMed
    Score: 0.082
  4. Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? AIDS. 2008 Mar 30; 22(6):671-83.
    View in: PubMed
    Score: 0.077
  5. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. Arch Intern Med. 2007 Mar 26; 167(6):597-605.
    View in: PubMed
    Score: 0.072
  6. Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s. J Infect Dis. 2003 Jan 15; 187(2):320-5.
    View in: PubMed
    Score: 0.053
  7. Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2. AIDS Res Hum Retroviruses. 2002 Jun 10; 18(9):661-5.
    View in: PubMed
    Score: 0.051
  8. A look at HIV immune research. Interview by Alan Huff. Res Initiat Treat Action. 2000 Sep; 6(3):30-3.
    View in: PubMed
    Score: 0.045
  9. Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production. J Clin Immunol. 1998 Mar; 18(2):124-31.
    View in: PubMed
    Score: 0.038
  10. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol. 1997 May; 4(3):358-61.
    View in: PubMed
    Score: 0.036
  11. Contribution of prostaglandin E2 to the interleukin-12 defect in HIV-infected patients. AIDS. 1996 Aug; 10(9):1043-5.
    View in: PubMed
    Score: 0.034
  12. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study. Medicine (Baltimore). 2016 Aug; 95(33):e4483.
    View in: PubMed
    Score: 0.034
  13. The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):163-71.
    View in: PubMed
    Score: 0.033
  14. CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. J Infect Dis. 1995 Nov; 172(5):1221-7.
    View in: PubMed
    Score: 0.032
  15. Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181. Clin Vaccine Immunol. 2010 Sep; 17(9):1452-9.
    View in: PubMed
    Score: 0.022
  16. Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection. J Acquir Immune Defic Syndr. 2007 May 01; 45(1):9-19.
    View in: PubMed
    Score: 0.018
  17. Characterization of circulating suppressor T lymphocytes in bone marrow transplant recipients. Transplantation. 1987 Feb; 43(2):258-63.
    View in: PubMed
    Score: 0.018
  18. Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study. J Infect Dis. 2006 Oct 15; 194(8):1098-107.
    View in: PubMed
    Score: 0.017
  19. In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol. 1997 Jan; 4(1):43-8.
    View in: PubMed
    Score: 0.009
  20. Transmembrane P-glycoprotein (P-gp/P-170) in HIV infection: analysis of lymphocyte surface expression and drug-unrelated function. AIDS Res Hum Retroviruses. 1995 Aug; 11(8):893-901.
    View in: PubMed
    Score: 0.008
  21. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA. 1994 Jan 05; 271(1):42-6.
    View in: PubMed
    Score: 0.007
  22. Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS. J Immunol. 1991 Apr 01; 146(7):2207-13.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.